0.85% -0.085

Evolus Inc (EOLS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1170)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

Prossima data di guadagno

Ultimi documenti SEC

EOLS's Discussions on Twitter

Confronta EOLS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EOLS Evolus Inc	9.885	632.51M	202.09M	-61.69M	-35.64M	-1.08
HLN Haleon Plc Adr	11.13	50.54B	14.35B	1.85B	0	0.4023
ZTS Zoetis Inc	170.85	74.02B	9.29B	2.52B	2.28B	5.57
RDHL Redhill Biopharma Ltd Adr	1.8368	4.22M	35.75M	11.57M	-26.25M	-3.8069
TAK Takeda Pharmaceutical Co Adr	14.96	45.82B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	17.20	20.31B	16.54B	-1.64B	749.00M	-1.45

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-17	Iniziato	BTIG Research	Buy
2024-01-29	Aggiornamento	Barclays	Equal Weight → Overweight
2022-06-23	Iniziato	Needham	Buy
2022-05-12	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-20	Aggiornamento	Truist	Hold → Buy
2021-05-06	Aggiornamento	Mizuho	Neutral → Buy
2021-04-08	Reiterato	H.C. Wainwright	Buy
2021-02-24	Downgrade	Truist	Buy → Hold
2020-07-07	Downgrade	Mizuho	Buy → Neutral
2020-02-06	Ripresa	Mizuho	Buy
2019-11-26	Iniziato	SVB Leerink	Outperform
2019-09-05	Ripresa	Mizuho	Buy
2019-06-28	Iniziato	Wells Fargo	Market Perform
2019-06-11	Iniziato	Barclays	Underweight
2019-03-20	Iniziato	SunTrust	Buy
2019-02-14	Iniziato	H.C. Wainwright	Buy
2019-01-29	Iniziato	Stifel	Buy

Mostra tutto

Evolus Inc Borsa (EOLS) Ultime notizie

Evolus Inc Azioni (EOLS) Dati Finanziari

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Confronta EOLS con altri titoli

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc Borsa (EOLS) Ultime notizie

Evolus Launches Second Product Line for Wrinkles - Orange County Business Journal

Evolus boosts balance sheet with lower-cost refinancing and flexibility - MSN

Evolus announces CFO resignation - MSN

Stifel maintains Evolus stock buy rating, $25 target - Investing.com Australia

Midday Stock Roundup: Activist Investor Targets El Pollo Loco - Orange County Business Journal

Stifel maintains Evolus stock buy rating, $25 target By Investing.com - Investing.com Nigeria

Increases to CEO Compensation Might Be Put On Hold For Now at Evolus, Inc. (NASDAQ:EOLS) - simplywall.st

Mizuho maintains Evolus stock Outperform rating and $25 target By Investing.com - Investing.com India

Evolus CFO Sandra Beaver resigns for new role By Investing.com - Investing.com South Africa

Mizuho maintains Evolus stock Outperform rating and $25 target - Investing.com

Evolus CFO to Resign - Orange County Business Journal

Evolus CFO Sandra Beaver Resigns - marketscreener.com

Evolus (EOLS) CFO Resignation Announced - GuruFocus

Evolus CFO Sandra Beaver Announces Resignation - TipRanks

Resignation of CFO Impacts Evolus (EOLS) Leadership | EOLS Stock News - GuruFocus

Evolus Announces Departure of its Chief Financial Officer | EOLS Stock News - GuruFocus

Evolus announces departure of CFO Sandra Beaver - TipRanks

Evolus CFO Sandra Beaver resigns for new role - Investing.com

Evolus Announces Departure Of Its Chief Financial Officer - marketscreener.com

Evolus Announces Departure of its Chief Financial Officer - Business Wire

Evolysse HA gels outperform Restylane in clinical study - Investing.com Australia

Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels - marketscreener.com

Evolus announces publication of U.S. pivotal study for Evolysse injectable gels - TipRanks

EOLS Publishes Promising Study Results on Evolysse Injectable Gels | EOLS Stock News - GuruFocus

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels - BioSpace

Evolysse HA gels outperform Restylane in clinical study By Investing.com - Investing.com Canada

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ - GuruFocus

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels | EOLS Stock News - GuruFocus

Trend Tracker for (EOLS) - news.stocktradersdaily.com

Deutsche Bank AG Cuts Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Comerica Bank Purchases New Stake in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to 16 newly hired non-executive employees - BioSpace

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Evolus Executives Sell Shares to Cover Tax Obligations - TradingView

Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Voya Investment Management LLC - Defense World

Evolus, Inc. (EOLS): A Bull Case Theory - Insider Monkey

Evolus (NASDAQ:EOLS) Earns Buy Rating from Needham & Company LLC - Defense World

Evolus projects $345M-$355M revenue for 2025 with new product launches - MSN

Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its First-Quarter Report - simplywall.st

Evolus, Inc. (NASDAQ:EOLS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Arcus Biosciences (RCUS) - The Globe and Mail

Evolus, Inc. Reports Strong Q1 Growth Amid Challenges - TipRanks

EOLS Stock: Needham Reiterates Buy Rating with $22 Target | EOLS Stock News - GuruFocus

Evolus, Inc. (NASDAQ:EOLS) Q1 2025 Earnings Call Transcript - Insider Monkey

What Analysts Are Saying About Evolus Stock - Benzinga

Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance

Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges By GuruFocus - Investing.com Canada

Evolus, Inc. Reports Strong Q1 2025 Growth - TipRanks

Earnings call transcript: Evolus Q1 2025 results miss forecasts, stock rises - Investing.com Nigeria

Evolus Inc Azioni (EOLS) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a EOLS